Fluence Fixtures Lead to Improved Product for Cannabis Cultivators Worldwide
Fluence, a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and food production, is helping global cannabis cultivators find operational stability by helping growers address cost efficiencies amid ongoing industry headwinds and energy market volatility.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230330005252/en/
Fluence LEDs provide high-efficiency and high-quality lighting without a significant impact on the localized power grid, or on temperature and humidity in the grow space at Chroni-Co. (Photo: Business Wire)
Cannabis growers around the world are feeling the effects of higher operating costs due to supply chain challenges and rapidly fluctuating energy prices, making it more important than ever for cultivators to invest in and integrate reliable, cost-saving solutions. Fluence’s LED technology VYPR series offer growers increased control over energy expenditure and a greater ability to customize light spectrum based on what works best for specific crops.
Replacing legacy high-pressure sodium (HPS) lighting systems with Fluence’s energy-efficient and environmentally friendly LED fixtures is one of the easiest ways to achieve cost savings and improve energy efficiency as well as reduce the impact on local power grids. Cannabis cultivators around the world, including many in North America, have also cut capital expenses by leveraging Fluence’s deep experience and guidance in helping partners receive energy efficiency rebates or subsidies in states with qualifying programs.
“Fluence’s LED lighting solutions are helping cannabis cultivators in North America and across Europe, the Middle East and Africa advance operational efficiency and profitability,” said Steve Graves, senior vice president of strategy and product at Fluence. “The VYPR product line enables growers to transition away from HPS lighting systems and save tens of thousands of dollars per year in energy consumption.”
Fluence’s horticultural and technical experts help partners to design, tailor and apply lighting solutions to specific facility footprints and meet their goals for plant growth and consistency. While growers have traditionally had to plan environmental control around the high heat output of HPS fixtures, VYPR fixtures and all other Fluence LEDs reduce interference with temperature and humidity in the grow space. Fluence’s in-house research and horticultural teams work closely with partners pre-, during and post-installation to adapt to the flexibility and control LEDs offer over environmental conditions for plant growth and operational scale.
Chroni-Co, a tenth-generation family-run commercial agriculture company in South Africa, chose to introduce medical cannabis into its portfolio of crops in 2019. They turned to Fluence for its industry leadership in LED grow lights and professional support for companies entering or already in cannabis production. Chroni-Co has taken advantage of the full range of Fluence products for upscaling production, sustainability and eco-friendliness, incorporating VYPR 2P, VYPR 3P and SPYDR 2X to aid the transition to cannabis cultivation while navigating growing a warm-weather crop against South Africa’s chilly winters.
“When we entered the medical cannabis space, we wanted to identify a lighting partner with a proven track record of supporting successful cannabis grows on a global scale whose work is backed by science and research,” said James Simpson, director and founder of Chroni-Co. “After meeting with Fluence, we knew we’d found a perfect match. Fluence’s VYPR and SPYDR solutions have helped us reduce our emissions and while lowering our operating expenses. More importantly, they’ve helped us provide our customers with a better, more consistent product.”
Early results at Chroni-Co are incredibly promising, with Fluence LEDs leading to a 30% increase in cannabinoid levels and improved morphology in cannabis plants—demonstrating the ability of Fluence products like VYPR and SPYDR to build highly successful, environmentally friendly cannabis harvests in harsh winter environments by offering better heat management and providing a balance for the lack of natural sunlight compared to HPS fixtures.
“Helping science-forward partners achieve a more consistent product and a healthier bottom line is the driving force behind what we do at Fluence,” said Timo Bongartz, general manager for Europe, the Middle East and Africa at Fluence. “Beneath Fluence LED technology, Chroni-Co’s medical-grade cannabis started as and has remained top-quality flower that is now sold to patients across Germany, a testament to the caliber of product and the ongoing globalization of the cannabis market that we are proud to play a part in.”
Fluence LED lighting solutions are available for purchase by licensed cultivators in territories in which the cultivation of cannabis is legal. For more information on Fluence, visit www.fluence.science.
About Fluence
Fluence Bioengineering, Inc. (Fluence) creates powerful and energy-efficient LED lighting solutions for commercial crop production and research applications. Fluence is a leading LED lighting supplier in the global cannabis market and is committed to enabling more efficient crop production with the world’s top vertical farms and greenhouse produce growers. Fluence global headquarters are in Austin, Texas, with its EMEA headquarters in Rotterdam, Netherlands. Fluence operates as a business unit within Signify’s Digital Solutions division. For more information about Fluence, visit www.fluence.science.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230330005252/en/
Contact information
For EMEA,
Silvia Nagyova
silvia.nagyova@fluence-led.com
+49 (89) 6213-3939
For North America,
Callie Neatherlin
callie@redfancommunications.com
512-439-9720
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Multi-Mission Beechcraft King Air Demonstrator Unveiled at Paris Air Show16.6.2025 09:30:00 EEST | Press release
Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company, announced its new multi-mission Beechcraft King Air demonstration aircraft will be making its show and European debut at the 2025 Paris Air Show. The aircraft is equipped to showcase a wide range of missions available on the versatile and reliable Beechcraft King Air platform, and will be on static display Monday, June 16, through Thursday, June 19, at the Textron Pavilion A2. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250615940392/en/ From Wichita, Kansas to Paris, France: Beechcraft King Air demonstrator makes international debut “The King Air’s acquisition and operation cost, combined with excellent speed, range and payload capacity make it an excellent value for a wide range of special missions,” said Bob Gibbs, vice president, Special Missions Sales. “The best-selling turboprop serves as an ideal platform for intelligence, surveillance and reconnaissance, ut
Ant International Announces Sustainability Framework, Serving 100 mn Merchants to Advance Inclusive Growth in Re-globalisation16.6.2025 08:00:00 EEST | Press release
Ant International, a leading global digital payment, digitisation and financial technology provider, today announced its Sustainability Framework in its first independent Sustainability Report. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250615891282/en/ Ant International announces Sustainability Framework in its Inaugural Sustainability Report A New Chapter of Growth with New Mission and Vision at a Critical Moment 2024 is a transformative year for Ant International, which became independent after a reorganisation of Ant Group. With headquarters in Singapore and over 30 offices around the world, Ant International provides cross-border digital payment, commerce and finance solutions to merchants and financial institutions, connecting 100 million+ merchants to global consumers across its 4 business units: global e-wallet gateway service (Alipay+), merchant payment service (Antom), cross-border business account service (Wor
Cosmetics Industry Icon Leonard A. Lauder, Chairman Emeritus, The Estée Lauder Companies, Passes Away15.6.2025 19:54:00 EEST | Press release
It is with deep sadness that The Estée Lauder Companies Inc. (NYSE: EL) announces that Chairman Emeritus Leonard A. Lauder passed away on June 14, at the age of 92, surrounded by family. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250615313230/en/ Leonard A. Lauder Mr. Lauder was born in 1933 in New York City, the oldest son of Estée and Joseph H. Lauder, the founders of The Estée Lauder Companies. He was a graduate of the Bronx High School of Science, the University of Pennsylvania’s Wharton School, and the Officer Candidate School of the United States Navy. Mr. Lauder studied at Columbia University’s Graduate School of Business. He served as a lieutenant in the U.S. Navy and as a Navy reservist, for which the U.S. Navy Supply Corps Foundation later recognized him with its Distinguished Alumni Award. He formally joined Estée Lauder in 1958, and for more than six decades, Mr. Lauder was a visionary and an innovator, helpi
Positive Late-Breaking Data for Incyte’s First-in-Class mutCALR-targeted therapy INCA033989 in Essential Thrombocythemia Presented at EHA202515.6.2025 10:15:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced the first clinical data from two studies evaluating the safety, tolerability and efficacy of INCA033989, a novel, first in class, Incyte-discovered, targeted monoclonal antibody in patients with mutant calreticulin (mutCALR)-expressing myeloproliferative neoplasms (MPNs). These data – featured today in the Late-Breaking Oral Session (#LB4002) at the European Hematology Association 2025 (EHA2025) Congress in Milan, Italy – focus on the dose escalation portion of thestudies in patients with high risk essential thrombocythemia (ET) who are resistant/intolerant to prior cytoreductive therapy. The studies evaluated the safety and efficacy of INCA033989 in patients with ET as measured by hematologic response and reduction in mutCALR variant allele frequency (VAF). Results as of April 4, 2025, showed rapid and durable normalization of platelet counts across all dose levels, with a trend toward improved responses in higher doses (>400 mg), in patients with
Perma-Pipe International Holdings, Inc. Announces First Quarter Fiscal 2025 Financial Results13.6.2025 16:14:00 EEST | Press release
Perma-Pipe International Holdings, Inc. (NASDAQ: PPIH) announced today financial results for the first quarter ended April 30, 2025. “Sales for the first quarter were $46.7 million, resulting in an increase of $12.4 million, or 36.2%, compared to $34.3 million in the same quarter last year. Net income attributable to common stock of $5.0 million was an increase of $3.6 million, or 243%, compared to $1.4 million in the first quarter of the prior year,” noted President and CEO Saleh Sagr. Backlog currently stands at $131.1 million, a decrease of $7.0 million, compared to $138.1 million at January 31, 2025. However, the Company has experienced a significant increase in backlog of $68.0 million, or 108%, compared to $63.1 million at April 30, 2024. We feel encouraged with the level of backlog we have obtained, which remains more than double the level of reported backlog at the end of the first quarter last year,” Mr. Sagr continued. “Our first quarter results represent unprecedented perfor
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom